DRG Team

General Manager
Mr. Jörg Schlößer

Mr. Joerg Schloesser is the General Manager for DRG Instruments GmbH, located in Marburg, Germany.

Mr. Schloesser joined DRG Instruments GmbH as General Manager in April 2022. He brings more than 25 years of extensive experience in general management, sales, market development and operations in the field of medical devices across Europe, Russia and EMEA regions. Prior to joining BioCheck/DRG, he served initially as the Sales and Marketing Director at RADIM Diagnostics, and was then appointed as the General Manager/Managing Director for the business for the past four years.

Mr. Schloesser received his master’s degree in Electro Engineering and Biomedical Engineering, and is also certified in Six Sigma Green Belt. He and his wife Stefanie have two daughters. In his spare time, he enjoys downhill skiing in the wintertime and bike riding in the summer.

Head of Research and Development
Dr. Matthias Herkert

Dr. Matthias Herkert is Director of Research and Development for DRG Instruments GmbH located in Marburg, Germany.

With approximately 20 years of experience at leading institutions, Dr. Herkert has a strong theoretical and practical knowledge in the fields of biochemistry and neuroscience, as well as ELISA assay development.

In 2008, Dr. Herkert joined DRG as Senior Scientist in the research and development department. He is responsible for development of new ELISA kits. He also oversees collaboration with project partners, including university hospitals and research groups. In addition, Dr. Herkert represents DRG in National and International Congresses.

Since 2012, Dr. Herkert is Director of Research and Development at DRG Instruments GmbH.

Before joining DRG Instruments, Dr. Herkert worked at the MTM Laboratories AG. In this role, he was appointed as the Head of Assay Development for Germany. His focus was primarily on development and early detection of cervical cancer.

Head of Production
Dr. Hero Brahms

Dr. Hero Brahms is the Head of Production for DRG Instruments GmbH.

In 2002, Dr. Brahms joined the DRG Group as a Developer in the German facility. An integral part of the research and development team of DRG Instruments, he was involved in the development and validation of new ELISAs. Along with his work in research and development, he is the Medical Security Manager of DRG Instruments.

Earlier in his career, Dr. Brahms worked in the field of Oligonucleotide synthesis at the Max-Planck-Institute for Experimental Medicine in Göttingen, Germany.

Dr. Brahms performed research as a postdoctoral scientist, both in immunology and molecular biology. His work on the role of posttranslational modifications in autoimmune diseases and cell biology at the Max-Planck-Institute for Biophysical Chemistry was awarded with the RPI/ RNA award for young scientists by the RNA Society, which is dedicated to the study of Ribonucleic Acid.

Head of QM/QA
Stefan Gansel

Project Management DRG:HYBRiD-XL
Mr. Marco Euler

Product Management ELISA / DRG:HYBRiD-XL
Ms. Julia Räder

Product Management Infectious Diseases / DxDATA^TM
Ms. Stefanie Lamers

Vice President of Sales Western & Central Europe
Mr. Andrey Krinitsyn

Head of Customer Service
Mr. Danijel Pavlic

Head of Warehouse
Mr. Volker Laucht